Antibiotic Dilution Calculator

The dilution identity C1 times V1 equals C2 times V2 follows from conservation of solute: adding solvent changes volume but not the number of antibiotic molecules present, so the product of concentration and volume is invariant. Rearranged, V1 equals C2 times V2 divided by C1 gives the aliquot of stock to draw, and the diluent to add is simply V2 minus V1. The relationship holds for any concentration unit as long as both concentrations use the same one, whether micrograms per mL, milligrams per mL or millimolar, and it assumes volumes are additive, which is a good approximation for dilute aqueous solutions but breaks down for concentrated organic solvents such as DMSO or ethanol. Practical accuracy, not algebra, sets the limits. Dilutions beyond roughly 100-fold in one step force pipetting of volumes near or below the reliable range of the instrument, so a 1:1000 dilution is normally split into sequential 10-fold steps to keep relative error low. Common laboratory working concentrations anchor the arithmetic: ampicillin at 100 micro-g/mL, kanamycin at 50, chloramphenicol at 25 to 34, tetracycline and gentamicin at 10 for bacterial selection, and penicillin-streptomycin at 100 units per mL with 100 micro-g/mL for cell culture. Susceptibility testing uses two-fold series typically spanning 0.06 to 128 micro-g/mL. Two further corrections are easy to miss: manufacturer potency, expressed as micrograms of active compound per milligram of powder, means an 850 micro-g/mg lot requires proportionally more powder, and heat-labile antibiotics must be filter-sterilized through a 0.22 micrometer membrane rather than autoclaved.

The arithmetic of dilution predates antibiotics entirely. It rests on the concept of solution concentration formalized during the nineteenth century as chemistry adopted quantitative volumetric analysis, and on the molar framework that followed from Avogadro's hypothesis and its later acceptance. Volumetric glassware, the burette and the analytical pipette gave chemists the means to prepare and verify standard solutions, and the conservation-of-solute rule became a routine bench calculation long before microbiology needed it. Antibiotics turned that routine into a standardized procedure. After Alexander Fleming observed penicillin's inhibitory effect in 1928 and wartime production made purified agents widely available in the 1940s, laboratories needed a reproducible way to state how much drug was required to inhibit a given organism. Serial two-fold broth dilution became the reference method for determining the minimum inhibitory concentration, and comparability across laboratories required agreement on inoculum size, medium, incubation and dilution scheme. An international collaborative study led by Ericsson and Sherris, reported in 1971, was influential in pushing toward standardization. In the United States that work was institutionalized by the National Committee for Clinical Laboratory Standards, founded in the 1960s and renamed the Clinical and Laboratory Standards Institute in 2005, whose M07 document defines dilution susceptibility testing methods still in use, while the European Committee on Antimicrobial Susceptibility Testing maintains a parallel European standard.